Preclinical models of AD, for example, are investigating the use of substances that activate the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway, a crucial regulator of antioxidant response and cellular protection [30]. The gene discussed is NFE2L2; the disease is Alzheimer disease.